Eli Lilly Co Drug Patent Portfolio

Eli Lilly Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Eli Lilly Co News

Overview of Pricing and Availability for Novo and Lilly's Weight Loss Medications - AOL.com

03 Apr, 2026

Novo Nordisk Implements Bold Pricing Approach for Wegovy During Company Restructuring

03 Apr, 2026

Eli Lilly and Company shares: Foundayo approval sparks potential surge in 2026? - Ad-hoc-news.de

03 Apr, 2026

Forecast: Eli Lilly's Upcoming Billion-Dollar Revenue Source Will Surprise You. (Clue: It's Not Related to Weight Loss Medications.)

02 Apr, 2026

See More